Skip to main content
GrowthR&D/Rev#87

Revenue CAGR 3Y

Share:

Research and development spending as a percentage of revenue. The ideal range depends on industry: tech companies often spend 15-25%. Too little may mean underinvestment in the future; too much may burden profitability.

Formula

Research & Development Expenses / Revenue x 100

Description

Measures the company's investment in innovation relative to its revenue. Adequate R&D spending is essential for maintaining competitive position in technology and pharmaceutical industries. Too little may indicate underinvestment in the future, while too much may burden near-term profitability.

Interpretation

The ideal range of 5-15% depends heavily on industry. Tech companies often spend 15-25%. Under 3% in a tech company may signal underinvestment. Above 25% may indicate the company has not yet found a scalable business model.

Log in to screen for Revenue CAGR 3Y

Related Growth Indicators

Share:

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.